171 related articles for article (PubMed ID: 9606832)
1. [Heparin effect on hydrolysis of fibrin clots in a bull and a man with varying fibrinolytic systems].
Makogonenko EM
Ukr Biokhim Zh (1978); 1997; 69(5-6):109-16. PubMed ID: 9606832
[TBL] [Abstract][Full Text] [Related]
2. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
[TBL] [Abstract][Full Text] [Related]
4. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
5. [Effects of heparin on plasmin and plasminogen activation].
Manmi S
Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
[No Abstract] [Full Text] [Related]
6. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
7. The fibrinolytic action of flufenamate and its influence on plasminogen binding to fibrin.
Chevallet-Prandini MH; Chapel A; Suscillon M
Thromb Res; 1985 Jun; 38(5):481-9. PubMed ID: 4012673
[TBL] [Abstract][Full Text] [Related]
8. [Antifibrinolytic effect of heparin].
Rozenfel'd MA; Leonova VB; Khavkina LS; Meshkov BB
Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
[TBL] [Abstract][Full Text] [Related]
9. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
10. Antithrombin-independent effects of heparins on fibrin clot nanostructure.
Yeromonahos C; Marlu R; Polack B; Caton F
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1320-4. PubMed ID: 22362760
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic agents and their effects on the haemostatic system.
Kluft C
Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
[TBL] [Abstract][Full Text] [Related]
12. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
13. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
[TBL] [Abstract][Full Text] [Related]
14. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
Singh K; Vézina C
J Med; 1974; 5(6):297-302. PubMed ID: 4528600
[No Abstract] [Full Text] [Related]
15. Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro.
Seale L; Finney S; Sawyer RT; Wallis RB
Thromb Haemost; 1997 May; 77(5):959-63. PubMed ID: 9184410
[TBL] [Abstract][Full Text] [Related]
16. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
[TBL] [Abstract][Full Text] [Related]
17. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
19. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
20. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
